in the news

Arrival of the Groninger INTEGRA

With the expansion of our viral drug product manufacturing facility in Rockville, Maryland well underway, we have begun outfitting our new viral manufacturing suites. The Groninger® INTEGRA, a state-of-the-art high speed fill/finish line with fully integrated isolator technology and automated inspection, labeling, and packaging, recently made it's journey from Germany to the US. The INTEGRA is an integral part of our strategic plan to continue supporting our clients in the fight against the COVID-19 pandemic and other life-threatening viral diseases. Since arriving at our facility, the Emergent team has been working diligently to complete installation and qualification of the new line and progress continues. 

Check out a few photos of the INTEGRA being shipped to Emergent! 

groninger_Covid-19-Linie_Integra (7)

groninger_Covid-19-Linie_Integra (1)

groninger_Covid-19-Linie_Integra (5)


Gene therapy solution: The value of a CDMO as your end-to-end partner

With ongoing advances in science and technology, the cell and gene therapy pipeline has grown especially robust over the past...


COVID-19: 'Pandemic-ready' set-up placing Emergent apart in CDMO Space

In a recent article with BioProcess International, Syed T. Husain, senior vice president & CDMO business unit head at Emergent...


Learn more about our site in Switzerland

Located in Thörishaus, Switzerland, just outside of Bern, our European-based site has expertise in mammalian, microbial, and...